HomePress ReleasesMilliporeSigma’s Danvers Facility Honored as a Manufacturer of the Year by Commonwealth’s Legislative Manufacturing Caucus

MilliporeSigma’s Danvers Facility Honored as a Manufacturer of the Year by Commonwealth’s Legislative Manufacturing Caucus

News Release

Burlington, Massachusetts, October 6, 2021 — MilliporeSigma, the U.S. and Canadian life science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, was selected as a Manufacturer of the Year for its Danvers facility at the 6th Annual Manufacturing Awards Ceremony.

The award was presented at the Massachusetts Manufacturing Mash-Up by the Commonwealth’s Legislative Manufacturing Caucus, a group of more than 60 legislators who focus on training for manufacturing employees, encouraging innovation by helping start-ups access resources, and expanding apprenticeship opportunities in key manufacturing sectors.

MilliporeSigma was nominated by Massachusetts State Senator Joan Lovely (D-Second Essex). “It is a true honor to nominate MilliporeSigma in Danvers for a Manufacturer of the Year Award,” said Senator Joan Lovely (D-Salem). “This annual event celebrates businesses and organizations that have made a positive impact on their community through manufacturing. MilliporeSigma continues to make medical and research advances for the health and safety of all, which has been especially significant in light of the Covid-19 pandemic. I would like to thank Chairs Eric Lesser and Jeffrey Roy of the Massachusetts Manufacturing Caucus for their leadership.”

“We are incredibly proud to receive the Manufacturer of the Year Award for our Danvers facility and thank Senator Joan Lovely for recognizing our contributions as an industry leader, especially here in Massachusetts,” said Chris Ross, head of Integrated Supply Chain Operations, MilliporeSigma. “The last 18 months have taught us many valuable lessons about the importance of our manufacturing capabilities and our readiness to meet the surging demands presented by the pandemic. Our Danvers Operations team has worked tirelessly in support of public health and nearly doubled its size over the last year. We look forward to continuing our collaboration with local officials and industry leaders to create even more opportunity for all within the manufacturing sector.”

MilliporeSigma’s Danvers facility supplies critical products to customers developing life-saving therapies, including Covid-19 vaccines, as well as products and services for biopharmaceutical manufacturing. The Danvers expansion project, which added 65,000 square feet of space to its single-use assembly operations, was recently completed and is fully operational. The expansion complements the existing 120,000-square-foot-facility and added needed support for the manufacturing of products across several portfolios. The total investment in Danvers is about $25 million and will add approximately 400 jobs throughout 2021. Recruiting is underway for a variety of manufacturing roles with no experience required. The company is participating in two upcoming job fairs :

  • October 13, 2021, 8 am-Noon; 3-7 pm, The UMass Lowell Inn and Conference Center, 50 Warren Street, Lowell, MA
  • October 13, 2021, 12-2 pm, Virtual Career Fair Life Science Consortium, N. Shore

In addition, MilliporeSigma will host a drive-through Career Fair at its Danvers, MA, facility on Wednesday, October 20, 2021, 10 am-6 pm at 54 Cherry Hill Drive, Danvers.

For more information, visit or

About the Life Science business of Merck KGaA, Darmstadt, Germany 

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 23,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.

Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck KGaA, Darmstadt, Germany generated sales of € 17.5 billion in 66 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit

All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service. 

Follow MilliporeSigma on Twitter @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.

Phone: 978-436-1725

Latest Press Releases

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?